Fentanyl (Durogesic /H)
Fentanyl
Janssen Pharmaceutica (Pty) Ltd
Registration
- Applicant
- Janssen Pharmaceutica (Pty) Ltd
- Registrations
- 5
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Durogesic 25 ug/h EACH PATCH CONTAINS FENTANYL 2,5 mg | 25 ug | 28028828/2.9/0288 | Registered | Not determined | None |
| Durogesic 50 ug/h EACH PATCH CONTAINS FENTANYL 5,0 mg | 50 ug | 28028928/2.9/0289 | Registered | Not determined | None |
| Durogesic 75 ug/h EACH PATCH CONTAINS FENTANYL 7,5 mg | 75 ug | 28029028/2.9/0290 | Registered | Not determined | None |
| Durogesic 100 ug/h EACH PATCH CONTAINS FENTANYL 10,0 mg | 100 ug | 28029128/2.9/0291 | Registered | Not determined | None |
| Durogesic 12 ug/h EACH PATCH CONTAINS FENTANYL 2,1 mg | 12 ug | A400203A40/2.9/0203 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S6: Fentanyl
- when intended for therapeutic purposes.
Consolidated Schedules 06 July 2026, line 10256
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
N-Phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide
Drag to rotate. Structure from PubChem CID 3345.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.